(Circulation. 2000;102:1126.)
© 2000 American Heart Association, Inc.
Clinical Investigation and Reports |
From the Department of Public Health (K.M., S.C., S.S.), University of Glasgow, Glasgow, UK; Information and Statistics Division (J.W.T.C., J.B., A.F., A.R.), Edinburgh, UK; Greater Glasgow Health Board (J.P.P.), Glasgow, UK; and the Department of Cardiology (J.J.V.M.), Western Infirmary, Glasgow, UK.
Correspondence to Professor John J.V. McMurray, CRI in Heart Failure, Wolfson Building, University of Glasgow, Glasgow G12 8QQ, UK. E-mail j.mcmurray{at}bio.gla.ac.uk
BackgroundContemporary survival in unselected patients with heart failure and the population impact of newer therapies have not been widely studied. Therefore, we have documented case-fatality rates (CFRs) over a recent 10-year period.
Methods and ResultsIn Scotland, all hospitalizations and deaths are captured on a single database. We have studied case fatality in all patients admitted with a principal diagnosis of heart failure from 1986 to 1995. A total of 66 547 patients (47% male) were studied. Median age was 72 years in men and 78 years in women. Crude CFRs at 30 days and at 1, 5, and 10 years were 19.9%, 44.5%, 76.5%, and 87.6%, respectively. Median survival was 1.47 years in men and 1.39 years in women (2.47 and 2.36 years, respectively, in those surviving 30 days). Age had a powerful effect on survival, and sex, comorbidity, and deprivation had modest effects. One-year CF was 24.2% in those aged <55 years and 58.1% in those aged >84 years. After adjustment, 30-day CFRs fell between 1986 and 1995, by 26% (95% CI 15 to 35, P<0.0001) in men and 17% (95% CI 6 to 26, P<0.0001) in women. Longer term CFRs fell by 18% (95% CI 13 to 24, P<0.0001) in men and 15% (95% CI 10 to 20, P<0.0001) in women. Median survival increased from 1.23 to 1.64 years.
ConclusionsHeart failure CF is much higher in the general population than in clinical trials, especially in the elderly. Although survival has increased significantly over the last decade, there is still much room for improvement.
Key Words: heart failure prognosis population epidemiology survival
This article has been cited by other articles:
![]() |
P A Mehta, S W Dubrey, H F McIntyre, D M Walker, S M C Hardman, G C Sutton, T A McDonagh, and M. R Cowie Improving survival in the 6 months after diagnosis of heart failure in the past decade: population-based data from the UK Heart, November 15, 2009; 95(22): 1851 - 1856. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Zannad, N. Agrinier, and F. Alla Heart failure burden and therapy Europace, November 1, 2009; 11(suppl_5): v1 - v9. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Setoguchi and L. W. Stevenson Hospitalizations in patients with heart failure: who and why. J. Am. Coll. Cardiol., October 27, 2009; 54(18): 1703 - 1705. [Full Text] [PDF] |
||||
![]() |
J. B. Somaratne, C. Berry, J. J.V. McMurray, K. K. Poppe, R. N. Doughty, and G. A. Whalley The prognostic significance of heart failure with preserved left ventricular ejection fraction: a literature-based meta-analysis Eur J Heart Fail, September 1, 2009; 11(9): 855 - 862. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Metra, E. Eichhorn, W. T. Abraham, J. Linseman, M. Bohm, R. Corbalan, D. DeMets, T. De Marco, U. Elkayam, M. Gerber, et al. Effects of low-dose oral enoximone administration on mortality, morbidity, and exercise capacity in patients with advanced heart failure: the randomized, double-blind, placebo-controlled, parallel group ESSENTIAL trials Eur. Heart J., August 22, 2009; (2009) ehp338v1. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Capewell, D. K. Hayes, E. S. Ford, J. A. Critchley, J. B. Croft, K. J. Greenlund, and D. R. Labarthe Life-Years Gained Among US Adults From Modern Treatments and Changes in the Prevalence of 6 Coronary Heart Disease Risk Factors Between 1980 and 2000 Am. J. Epidemiol., July 15, 2009; 170(2): 229 - 236. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Najafi, K. Jamrozik, and A. J. Dobson Understanding the 'epidemic of heart failure': a systematic review of trends in determinants of heart failure Eur J Heart Fail, May 1, 2009; 11(5): 472 - 479. [Abstract] [Full Text] [PDF] |
||||
![]() |
P H Gibson, B L Croal, B H Cuthbertson, G Gibson, R R Jeffrey, K G Buchan, H El-Shafei, and G S Hillis Socio-economic status and early outcome from coronary artery bypass grafting Heart, May 1, 2009; 95(10): 793 - 798. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Shafazand, M. Schaufelberger, G. Lappas, K. Swedberg, and A. Rosengren Survival trends in men and women with heart failure of ischaemic and non-ischaemic origin: data for the period 1987-2003 from the Swedish Hospital Discharge Registry Eur. Heart J., March 2, 2009; 30(6): 671 - 678. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Wedel, J. J.V. McMurray, M. Lindberg, J. Wikstrand, J. G.F. Cleland, J. H. Cornel, P. Dunselman, A. Hjalmarson, J. Kjekshus, M. Komajda, et al. Predictors of fatal and non-fatal outcomes in the Controlled Rosuvastatin Multinational Trial in Heart Failure (CORONA): incremental value of apolipoprotein A-1, high-sensitivity C-reactive peptide and N-terminal pro B-type natriuretic peptide Eur J Heart Fail, March 1, 2009; 11(3): 281 - 291. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Castellant, M. Fatemi, E. Orhan, Y. Etienne, and J. J. Blanc Patients with non-ischaemic dilated cardiomyopathy and hyper-responders to cardiac resynchronization therapy: characteristics and long-term evolution Europace, March 1, 2009; 11(3): 350 - 355. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. S. Jhund, K. MacIntyre, C. R. Simpson, J. D. Lewsey, S. Stewart, A. Redpath, J. W.T. Chalmers, S. Capewell, and J. J.V. McMurray Long-Term Trends in First Hospitalization for Heart Failure and Subsequent Survival Between 1986 and 2003: A Population Study of 5.1 Million People Circulation, February 3, 2009; 119(4): 515 - 523. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Pfisterer, P. Buser, H. Rickli, M. Gutmann, P. Erne, P. Rickenbacher, A. Vuillomenet, U. Jeker, P. Dubach, H. Beer, et al. BNP-Guided vs Symptom-Guided Heart Failure Therapy: The Trial of Intensified vs Standard Medical Therapy in Elderly Patients With Congestive Heart Failure (TIME-CHF) Randomized Trial JAMA, January 28, 2009; 301(4): 383 - 392. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. McMurray, M. Petrie, K. Swedberg, M. Komajda, S. Anker, and R. Gardner CHAPTER 23 Heart Failure ESC Textbook of Cardiovascular Medicine, January 1, 2009; 2(1): med-9780199566990-chapter - med-9780199566990-chapter. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Stork, H. W. Hense, C. Zentgraf, I. Uebelacker, R. Jahns, G. Ertl, and C. E. Angermann Pharmacotherapy according to treatment guidelines is associated with lower mortality in a community-based sample of patients with chronic heart failure A prospective cohort study Eur J Heart Fail, December 1, 2008; 10(12): 1236 - 1245. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. R. MacDonald, P. S. Jhund, M. C. Petrie, J. D. Lewsey, N. M. Hawkins, S. Bhagra, N. Munoz, F. Varyani, A. Redpath, J. Chalmers, et al. Discordant Short- and Long-Term Outcomes Associated With Diabetes in Patients With Heart Failure: Importance of Age and Sex: A Population Study of 5.1 Million People in Scotland Circ Heart Fail, November 1, 2008; 1(4): 234 - 241. [Abstract] [Full Text] [PDF] |
||||
![]() |
Authors/Task Force Members, K. Dickstein, A. Cohen-Solal, G. Filippatos, J. J.V. McMurray, P. Ponikowski, P. A. Poole-Wilson, A. Stromberg, D. J. van Veldhuisen, D. Atar, et al. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM) Eur. Heart J., October 1, 2008; 29(19): 2388 - 2442. [Full Text] [PDF] |
||||
![]() |
K. Dickstein, A. Cohen-Solal, G. Filippatos, J. J.V. McMurray, P. Ponikowski, P. A. Poole-Wilson, A. Stromberg, D. J. van Veldhuisen, D. Atar, A. W. Hoes, et al. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM) Eur J Heart Fail, October 1, 2008; 10(10): 933 - 989. [Full Text] [PDF] |
||||
![]() |
L. Erhardt, M. Komajda, F.D. R. Hobbs, and J. Soler-Soler Cardiologists' awareness and perceptions of guidelines for chronic heart failure. The ADDress your Heart survey Eur J Heart Fail, October 1, 2008; 10(10): 1020 - 1025. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Derval, L. Barandon, P. Dufourcq, L. Leroux, J.-M. D. Lamaziere, D. Daret, T. Couffinhal, and C. Duplaa Epicardial deposition of endothelial progenitor and mesenchymal stem cells in a coated muscle patch after myocardial infarction in a murine model. Eur. J. Cardiothorac. Surg., August 1, 2008; 34(2): 248 - 254. [Abstract] [Full Text] [PDF] |
||||
![]() |
Meta-analysis Research Group in Echocardiography ( Independence of restrictive filling pattern and LV ejection fraction with mortality in heart failure: An individual patient meta-analysis Eur J Heart Fail, August 1, 2008; 10(8): 786 - 792. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. R. MacDonald, M. C. Petrie, N. M. Hawkins, J. R. Petrie, M. Fisher, R. McKelvie, D. Aguilar, H. Krum, and J. J.V. McMurray Diabetes, left ventricular systolic dysfunction, and chronic heart failure Eur. Heart J., May 2, 2008; 29(10): 1224 - 1240. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. F. Lewis, E. J. Velazquez, S. D. Solomon, A. S. Hellkamp, J. J.V. McMurray, J. Mathias, J.-L. Rouleau, A. P. Maggioni, K. Swedberg, L. Kober, et al. Predictors of the first heart failure hospitalization in patients who are stable survivors of myocardial infarction complicated by pulmonary congestion and/or left ventricular dysfunction: a VALIANT study Eur. Heart J., March 2, 2008; 29(6): 748 - 756. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Barnes, M. Gott, S. Payne, C. Parker, D. Seamark, S. Gariballa, and N. Small Predicting mortality among a general practice-based sample of older people with heart failure Chronic Illness, March 1, 2008; 4(1): 5 - 12. [Abstract] [PDF] |
||||
![]() |
R. C. Myles, C. E. Jackson, I. Tsorlalis, M. C. Petrie, J. J. V. McMurray, and S. M. Cobbe Is Microvolt T-Wave Alternans the Answer to Risk Stratification in Heart Failure? Circulation, December 18, 2007; 116(25): 2984 - 2991. [Full Text] [PDF] |
||||
![]() |
D. Banerjee, J. Z. Ma, A. J. Collins, and C. A. Herzog Long-Term Survival of Incident Hemodialysis Patients Who Are Hospitalized for Congestive Heart Failure, Pulmonary Edema, or Fluid Overload Clin. J. Am. Soc. Nephrol., November 1, 2007; 2(6): 1186 - 1190. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Mosterd and A. W Hoes Clinical epidemiology of heart failure Heart, September 1, 2007; 93(9): 1137 - 1146. [Full Text] [PDF] |
||||
![]() |
A. J. Peacock, N. F. Murphy, J. J. V. McMurray, L. Caballero, and S. Stewart An epidemiological study of pulmonary arterial hypertension Eur. Respir. J., July 1, 2007; 30(1): 104 - 109. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. F Murphy, C. R Simpson, P. S Jhund, S. Stewart, M. Kirkpatrick, J. Chalmers, K. MacIntyre, and J. J V McMurray A national survey of the prevalence, incidence, primary care burden and treatment of atrial fibrillation in Scotland Heart, May 1, 2007; 93(5): 606 - 612. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. J. Goldberg, J. Ciampa, D. Lessard, T. E. Meyer, and F. A. Spencer Long-term Survival After Heart Failure: A Contemporary Population-Based Perspective Arch Intern Med, March 12, 2007; 167(5): 490 - 496. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Stewart, N.F. Murphy, J.J.V. McMurray, P. Jhund, C.L. Hart, and D. Hole Effect of socioeconomic deprivation on the population risk of incident heart failure hospitalisation: An analysis of the Renfrew/Paisley Study Eur J Heart Fail, December 1, 2006; 8(8): 856 - 863. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Skali, M. A. Pfeffer, J. Lubsen, and S. D. Solomon Variable Impact of Combining Fatal and Nonfatal End Points in Heart Failure Trials Circulation, November 21, 2006; 114(21): 2298 - 2303. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. S. Nieminen, D. Brutsaert, K. Dickstein, H. Drexler, F. Follath, V.-P. Harjola, M. Hochadel, M. Komajda, J. Lassus, J. L. Lopez-Sendon, et al. EuroHeart Failure Survey II (EHFS II): a survey on hospitalized acute heart failure patients: description of population Eur. Heart J., November 2, 2006; 27(22): 2725 - 2736. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. R. van Kimmenade, J. L. Januzzi Jr, P. T. Ellinor, U. C. Sharma, J. A. Bakker, A. F. Low, A. Martinez, H. J. Crijns, C. A. MacRae, P. P. Menheere, et al. Utility of Amino-Terminal Pro-Brain Natriuretic Peptide, Galectin-3, and Apelin for the Evaluation of Patients With Acute Heart Failure J. Am. Coll. Cardiol., September 19, 2006; 48(6): 1217 - 1224. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Monte, A. Macchia, F. Pellegrini, M. Romero, V. Lepore, A. D'Ettorre, M. Saugo, L. Tavazzi, and G. Tognoni Antithrombotic treatment is strongly underused despite reducing overall mortality among high-risk elderly patients hospitalized with atrial fibrillation Eur. Heart J., September 2, 2006; 27(18): 2217 - 2223. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. D. Smit, P. F.H.M. Van Dessel, M. Rienstra, W. Nieuwland, A. C.P. Wiesfeld, E. S. Tan, R. L. Anthonio, D. J. Van Veldhuisen, and I. C. Van Gelder Atrial fibrillation predicts appropriate shocks in primary prevention implantable cardioverter-defibrillator patients. Europace, August 1, 2006; 8(8): 566 - 572. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. S. Chong, R. S. Gardner, J. J. Morton, E. A. Ashley, and T. A. McDonagh Plasma concentrations of the novel peptide apelin are decreased in patients with chronic heart failure Eur J Heart Fail, June 1, 2006; 8(4): 355 - 360. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Silke Beta-blockade in CHF: pathophysiological considerations Eur. Heart J. Suppl., June 1, 2006; 8(suppl_C): C13 - C18. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. R. Davis, L. B. Piller, J. A. Cutler, C. Furberg, K. Dunn, S. Franklin, D. Goff, F. Leenen, S. Mohiuddin, V. Papademetriou, et al. Role of Diuretics in the Prevention of Heart Failure: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial Circulation, May 9, 2006; 113(18): 2201 - 2210. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Eschenhagen, W. H. Zimmermann, and A. G. Kleber Electrical Coupling of Cardiac Myocyte Cell Sheets to the Heart Circ. Res., March 17, 2006; 98(5): 573 - 575. [Full Text] [PDF] |
||||
![]() |
W. H. Barker, J. P. Mullooly, and W. Getchell Changing Incidence and Survival for Heart Failure in a Well-Defined Older Population, 1970-1974 and 1990-1994 Circulation, February 14, 2006; 113(6): 799 - 805. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. H.M. van Jaarsveld, A. V. Ranchor, G. I.J.M. Kempen, J. C. Coyne, D. J. van Veldhuisen, and R. Sanderman Epidemiology of heart failure in a community-based study of subjects aged >=57 years: Incidence and long-term survival Eur J Heart Fail, January 1, 2006; 8(1): 23 - 30. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J. Lenzen, E. Boersma, W. J.M. Scholte op Reimer, A. H.M.M. Balk, M. Komajda, K. Swedberg, F. Follath, M. Jimenez-Navarro, M. L. Simoons, and J. G.F. Cleland Under-utilization of evidence-based drug treatment in patients with heart failure is only partially explained by dissimilarity to patients enrolled in landmark trials: a report from the Euro Heart Survey on Heart Failure Eur. Heart J., December 2, 2005; 26(24): 2706 - 2713. [Abstract] [Full Text] [PDF] |
||||
![]() |
I Gemmell, R F Heller, P McElduff, K Payne, G Butler, R Edwards, M Roland, and P Durrington Population impact of stricter adherence to recommendations for pharmacological and lifestyle interventions over one year in patients with coronary heart disease J Epidemiol Community Health, December 1, 2005; 59(12): 1041 - 1046. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Grigorian Shamagian, J. R. Gonzalez-Juanatey, A. V. Roman, J. M. G. Acuna, and A. V. Lamela The death rate among hospitalized heart failure patients with normal and depressed left ventricular ejection fraction in the year following discharge: evolution over a 10-year period Eur. Heart J., November 1, 2005; 26(21): 2251 - 2258. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. S. Lee, J. V. Tu, D. N. Juurlink, D. A. Alter, D. T. Ko, P. C. Austin, A. Chong, T. A. Stukel, D. Levy, and A. Laupacis Risk-Treatment Mismatch in the Pharmacotherapy of Heart Failure JAMA, September 14, 2005; 294(10): 1240 - 1247. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Galve, A. Mallol, R. Catalan, J. Palet, S. Mendez, E. Nieto, A. Diaz, and J. Soler-Soler Clinical and neurohumoral consequences of diuretic withdrawal in patients with chronic, stabilized heart failure and systolic dysfunction Eur J Heart Fail, August 1, 2005; 7(5): 892 - 898. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Ojeda, M. Anguita, M. Delgado, F. Atienza, C. Rus, A. L. Granados, F. Ridocci, F. Valles, and J. A. Velasco Short- and long-term results of a programme for the prevention of readmissions and mortality in patients with heart failure: Are effects maintained after stopping the programme? Eur J Heart Fail, August 1, 2005; 7(5): 921 - 926. [Abstract] [Full Text] [PDF] |
||||
![]() |
C Berry, K Hogg, J Norrie, K Stevenson, M Brett, and J McMurray Heart failure with preserved left ventricular systolic function: a hospital cohort study Heart, July 1, 2005; 91(7): 907 - 913. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Dunderdale, D. R. Thompson, J. N.V. Miles, S. F. Beer, and G. Furze Quality-of-life measurement in chronic heart failure: do we take account of the patient perspective? Eur J Heart Fail, June 1, 2005; 7(4): 572 - 582. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. R. Thompson, A. Roebuck, and S. Stewart Effects of a nurse-led, clinic and home-based intervention on recurrent hospital use in chronic heart failure Eur J Heart Fail, March 16, 2005; 7(3): 377 - 384. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. T. Yan, R. T. Yan, and P. P. Liu Narrative Review: Pharmacotherapy for Chronic Heart Failure: Evidence from Recent Clinical Trials Ann Intern Med, January 18, 2005; 142(2): 132 - 145. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Unal, J. A. Critchley, D. Fidan, and S. Capewell Life-Years Gained From Modern Cardiological Treatments and Population Risk Factor Changes in England and Wales, 1981-2000 Am J Public Health, January 1, 2005; 95(1): 103 - 108. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-J. Blanc, M. Fatemi, V.ér. Bertault, F. Baraket, and Y. Etienne Evaluation of left bundle branch block as a reversible cause of non-ischaemic dilated cardiomyopathy with severe heart failure. A new concept of left ventricular dyssynchrony-induced cardiomyopathy Europace, January 1, 2005; 7(6): 604 - 610. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. J.V. McMurray and M. A. Pfeffer The year in heart failure J. Am. Coll. Cardiol., December 21, 2004; 44(12): 2398 - 2405. [Full Text] [PDF] |
||||
![]() |
J. B. Young, M. E. Dunlap, M. A. Pfeffer, J. L. Probstfield, A. Cohen-Solal, R. Dietz, C. B. Granger, J. Hradec, J. Kuch, R. S. McKelvie, et al. Mortality and Morbidity Reduction With Candesartan in Patients With Chronic Heart Failure and Left Ventricular Systolic Dysfunction: Results of the CHARM Low-Left Ventricular Ejection Fraction Trials Circulation, October 26, 2004; 110(17): 2618 - 2626. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Gustafsson, C. Torp-Pedersen, M. Seibaek, H. Burchardt, L. Kober, and for the DIAMOND study group Effect of age on short and long-term mortality in patients admitted to hospital with congestive heart failure Eur. Heart J., October 1, 2004; 25(19): 1711 - 1717. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Barandon, T. Couffinhal, P. Dufourcq, P. Alzieu, D. Daret, C. Deville, and C. Duplaa Repair of Myocardial Infarction by Epicardial Deposition of Bone Marrow Cell-Coated Muscle Patch in a Murine Model Ann. Thorac. Surg., October 1, 2004; 78(4): 1409 - 1417. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Opasich, S. De Feo, G.A. Ambrosio, P. Bellis, A. Di Lenarda, G. Di Tano, D. Fico, L. Gonzini, R. Lavecchia, C. Tomasi, et al. The 'real' woman with heart failure. Impact of sex on current in-hospital management of heart failure by cardiologists and internists Eur J Heart Fail, October 1, 2004; 6(6): 769 - 779. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Kimmelstiel, D. Levine, K. Perry, A. R. Patel, A. Sadaniantz, N. Gorham, M. Cunnie, L. Duggan, L. Cotter, P. Shea-Albright, et al. Randomized, Controlled Evaluation of Short- and Long-Term Benefits of Heart Failure Disease Management Within a Diverse Provider Network: The SPAN-CHF Trial Circulation, September 14, 2004; 110(11): 1450 - 1455. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. A. McAlister, J. A. Ezekowitz, N. Wiebe, B. Rowe, C. Spooner, E. Crumley, L. Hartling, T. Klassen, and W. Abraham Systematic Review: Cardiac Resynchronization in Patients with Symptomatic Heart Failure Ann Intern Med, September 7, 2004; 141(5): 381 - 390. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Critchley, J. Liu, D. Zhao, W. Wei, and S. Capewell Explaining the Increase in Coronary Heart Disease Mortality in Beijing Between 1984 and 1999 Circulation, September 7, 2004; 110(10): 1236 - 1244. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Gustafsson and J. M. O. Arnold Heart failure clinics and outpatient management: review of the evidence and call for quality assurance Eur. Heart J., September 2, 2004; 25(18): 1596 - 1604. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. S. Bleumink, A. M. Knetsch, M. C.J.M. Sturkenboom, S. M.J.M. Straus, A. Hofman, J. W. Deckers, J. C.M. Witteman, and B. H.Ch. Stricker Quantifying the heart failure epidemic: prevalence, incidence rate, lifetime risk and prognosis of heart failure: The Rotterdam Study Eur. Heart J., September 2, 2004; 25(18): 1614 - 1619. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. A. McAlister, S. Stewart, S. Ferrua, and J. J.J.V. McMurray Multidisciplinary strategies for the management of heart failure patients at high risk for admission: A systematic review of randomized trials J. Am. Coll. Cardiol., August 18, 2004; 44(4): 810 - 819. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Muntwyler, A. Cohen-Solal, N. Freemantle, J. Eastaugh, J. G. Cleland, and F. Follath Relation of sex, age and concomitant diseases to drug prescription for heart failure in primary care in Europe Eur J Heart Fail, August 1, 2004; 6(5): 663 - 668. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. L. Roger, S. A. Weston, M. M. Redfield, J. P. Hellermann-Homan, J. Killian, B. P. Yawn, and S. J. Jacobsen Trends in Heart Failure Incidence and Survival in a Community-Based Population JAMA, July 21, 2004; 292(3): 344 - 350. [Abstract] [Full Text] [PDF] |
||||
![]() |
F A McAlister, N F Murphy, C R Simpson, S Stewart, K MacIntyre, M Kirkpatrick, J Chalmers, A Redpath, S Capewell, and J J V McMurray Influence of socioeconomic deprivation on the primary care burden and treatment of patients with a diagnosis of heart failure in general practice in Scotland: population based study BMJ, May 8, 2004; 328(7448): 1110. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Gustafsson, B. Brendorp, M. Seibaek, H. Burchardt, P. Hildebrandt, L. Kober, C. Torp-Pedersen, and DIAMOND Study Group Influence of diabetes and diabetes-gender interaction on the risk of death in patients hospitalized with congestive heart failure J. Am. Coll. Cardiol., March 3, 2004; 43(5): 771 - 777. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. A. McAlister, J. Ezekowitz, M. Tonelli, and P. W. Armstrong Renal Insufficiency and Heart Failure: Prognostic and Therapeutic Implications From a Prospective Cohort Study Circulation, March 2, 2004; 109(8): 1004 - 1009. [Abstract] [Full Text] [PDF] |
||||
![]() |
S Stewart, N Murphy, A Walker, A McGuire, and J J V McMurray Cost of an emerging epidemic: an economic analysis of atrial fibrillation in the UK Heart, March 1, 2004; 90(3): 286 - 292. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Tendera The epidemiology of heart failure Journal of Renin-Angiotensin-Aldosterone System, March 1, 2004; 5(1_suppl): S2 - S6. [Abstract] [PDF] |
||||
![]() |
M. Metra, S. Nodari, and L. Dei Cas Current guidelines in the pharmacological management of chronic heart failure Journal of Renin-Angiotensin-Aldosterone System, March 1, 2004; 5(1_suppl): S11 - S16. [Abstract] [PDF] |
||||
![]() |
M. T. Kearney and M. Marber Trends in incidence and prognosis of heart failure: You always pass failure on the way to success Eur. Heart J., February 2, 2004; 25(4): 283 - 284. [Full Text] [PDF] |
||||
![]() |
M. Schaufelberger, K. Swedberg, M. Koster, M. Rosen, and A. Rosengren Decreasing one-year mortality and hospitalization rates for heart failure in Sweden: Data from the Swedish Hospital Discharge Registry 1988 to 2000 Eur. Heart J., February 2, 2004; 25(4): 300 - 307. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Formiga, D. Chivite, N. Manito, V. Osma, S. Miravet, and R. Pujol One-year follow-up of heart failure patients after their first admission QJM, February 1, 2004; 97(2): 81 - 86. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Gustafsson, C. Torp-Pedersen, H. Burchardt, P. Buch, M. Seibaek, E. Kjoller, I. Gustafsson, L. Kober, and for the DIAMOND Study group Female sex is associated with a better long-term survival in patients hospitalized with congestive heart failure Eur. Heart J., January 2, 2004; 25(2): 129 - 135. [Abstract] [Full Text] [PDF] |
||||
![]() |
G Lyratzopoulos and R F Heller Prognosis for South Asian and white patients with heart failure in the United Kingdom: Deprivation gradient in mortality should not be dismissed as artefactual BMJ, December 13, 2003; 327(7428): 1406 - 1406. [Full Text] |
||||
![]() |
I. Squire, J. Newton, and H. Blackledge Prognosis for South Asian and white patients with heart failure in the United Kingdom: Authors' reply BMJ, December 13, 2003; 327(7428): 1406 - 1406. [Full Text] |
||||
![]() |
P. Le Corvoisier, H.-Y. Park, K. M. Carlson, D. A. Marchuk, and H. A. Rockman Multiple quantitative trait loci modify the heart failure phenotype in murine cardiomyopathy Hum. Mol. Genet., December 1, 2003; 12(23): 3097 - 3107. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. C. Vourvouri, A. F.L. Schinkel, J. R.T.C. Roelandt, F. Boomsma, G. Sianos, M. Bountioukos, F. B. Sozzi, V. Rizzello, J. J. Bax, H. I. Karvounis, et al. Screening for left ventricular dysfunction using a hand-carried cardiac ultrasound device Eur J Heart Fail, December 1, 2003; 5(6): 767 - 774. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. L. Ng, I. Loke, J. E. Davies, K. Khunti, M. Stone, K. R. Abrams, D. T. Chin, and I. B. Squire Identification of previously undiagnosed left ventricular systolic dysfunction: community screening using natriuretic peptides and electrocardiography Eur J Heart Fail, December 1, 2003; 5(6): 775 - 782. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Muller, G. Gamba, F. Jaquet, and B. Hess Torasemide vs. furosemide in primary care patients with chronic heart failure NYHA II to IV--efficacy and quality of life Eur J Heart Fail, December 1, 2003; 5(6): 793 - 801. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. S. Lee, P. C. Austin, J. L. Rouleau, P. P. Liu, D. Naimark, and J. V. Tu Predicting Mortality Among Patients Hospitalized for Heart Failure: Derivation and Validation of a Clinical Model JAMA, November 19, 2003; 290(19): 2581 - 2587. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. M Blackledge, J. Newton, and I. B Squire Prognosis for South Asian and white patients newly admitted to hospital with heart failure in the United Kingdom: historical cohort study BMJ, September 6, 2003; 327(7414): 526 - 531. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Schalcher, H. Rickli, M. Brehm, D. Weilenmann, E. Oechslin, W. Kiowski, and H. P. Brunner-La Rocca Prolonged Oxygen Uptake Kinetics During Low-Intensity Exercise Are Related to Poor Prognosis in Patients With Mild-to-Moderate Congestive Heart Failure Chest, August 1, 2003; 124(2): 580 - 586. [Abstract] [Full Text] [PDF] |
||||
![]() |
T P Ng and M Niti Trends and ethnic differences in hospital admissions and mortality for congestive heart failure in the elderly in Singapore, 1991 to 1998 Heart, August 1, 2003; 89(8): 865 - 870. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. J. O'Brien, I. B. Squire, B. Demme, J. E. Davies, and L. L. Ng Pre-discharge, but not admission, levels of NT-proBNP predict adverse prognosis following acute LVF Eur J Heart Fail, August 1, 2003; 5(4): 499 - 506. [Abstract] [Full Text] [PDF] |
||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2000 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |